Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature, Diseases | 2 | 2021 | 26 | 0.550 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2014 | 12 | 0.490 |
Why?
|
| Hypertension, Pulmonary | 2 | 2014 | 23 | 0.490 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 6 | 0.390 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 34 | 0.380 |
Why?
|
| src-Family Kinases | 1 | 2009 | 16 | 0.310 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 122 | 0.300 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2022 | 35 | 0.280 |
Why?
|
| Brachyura | 1 | 2006 | 1 | 0.240 |
Why?
|
| Gills | 1 | 2006 | 1 | 0.240 |
Why?
|
| Sodium Chloride | 1 | 2006 | 26 | 0.240 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2006 | 28 | 0.240 |
Why?
|
| Infant, Newborn | 6 | 2022 | 730 | 0.200 |
Why?
|
| Infant, Premature | 5 | 2022 | 80 | 0.190 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 12 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2022 | 214 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2016 | 50 | 0.130 |
Why?
|
| Weight Perception | 1 | 2016 | 2 | 0.120 |
Why?
|
| Thinness | 1 | 2016 | 34 | 0.120 |
Why?
|
| Parents | 1 | 2016 | 159 | 0.110 |
Why?
|
| Logistic Models | 2 | 2014 | 808 | 0.100 |
Why?
|
| Overweight | 1 | 2016 | 288 | 0.100 |
Why?
|
| Placenta | 1 | 2014 | 76 | 0.100 |
Why?
|
| Intensive Care, Neonatal | 2 | 2003 | 11 | 0.100 |
Why?
|
| Benchmarking | 2 | 2003 | 26 | 0.100 |
Why?
|
| Intracranial Hemorrhages | 2 | 2003 | 35 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 44 | 0.100 |
Why?
|
| Echoencephalography | 2 | 2021 | 4 | 0.090 |
Why?
|
| Male | 6 | 2022 | 20697 | 0.090 |
Why?
|
| Brain Ischemia | 2 | 2003 | 160 | 0.090 |
Why?
|
| Female | 6 | 2022 | 21490 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2009 | 18 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2009 | 17 | 0.080 |
Why?
|
| Superoxides | 1 | 2009 | 24 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 46 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2009 | 148 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 91 | 0.080 |
Why?
|
| Pediatrics | 1 | 2011 | 167 | 0.070 |
Why?
|
| Protein Binding | 1 | 2009 | 255 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2009 | 264 | 0.070 |
Why?
|
| Cell Line | 1 | 2009 | 476 | 0.070 |
Why?
|
| Macrophages | 1 | 2009 | 216 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3812 | 0.070 |
Why?
|
| Calcium | 1 | 2009 | 343 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1910 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2011 | 330 | 0.060 |
Why?
|
| Animals | 3 | 2009 | 8544 | 0.060 |
Why?
|
| Humans | 8 | 2022 | 34474 | 0.060 |
Why?
|
| Hemolymph | 1 | 2006 | 1 | 0.060 |
Why?
|
| Fresh Water | 1 | 2006 | 3 | 0.060 |
Why?
|
| Seawater | 1 | 2006 | 3 | 0.060 |
Why?
|
| Ion Transport | 1 | 2006 | 6 | 0.060 |
Why?
|
| Acclimatization | 1 | 2006 | 3 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2006 | 17 | 0.060 |
Why?
|
| Infant | 2 | 2022 | 1122 | 0.060 |
Why?
|
| Mice | 2 | 2009 | 2691 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 4136 | 0.050 |
Why?
|
| Health Plan Implementation | 1 | 2003 | 19 | 0.050 |
Why?
|
| ras Proteins | 1 | 2002 | 10 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 18 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2002 | 57 | 0.050 |
Why?
|
| Gestational Age | 1 | 2022 | 134 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2002 | 192 | 0.040 |
Why?
|
| Critical Care | 1 | 2021 | 113 | 0.040 |
Why?
|
| United States | 3 | 2021 | 4267 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 500 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 1261 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 2461 | 0.030 |
Why?
|
| Term Birth | 1 | 2016 | 5 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2613 | 0.030 |
Why?
|
| Adult | 2 | 2022 | 10015 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 3799 | 0.030 |
Why?
|
| Total Quality Management | 2 | 2003 | 19 | 0.020 |
Why?
|
| Organizational Innovation | 2 | 2003 | 34 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 953 | 0.020 |
Why?
|
| Cooperative Behavior | 2 | 2003 | 87 | 0.020 |
Why?
|
| Evidence-Based Medicine | 2 | 2003 | 230 | 0.020 |
Why?
|
| North Carolina | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Models, Educational | 1 | 2011 | 22 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 214 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 217 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2011 | 349 | 0.020 |
Why?
|
| High-Frequency Ventilation | 1 | 2003 | 1 | 0.010 |
Why?
|
| Indomethacin | 1 | 2003 | 7 | 0.010 |
Why?
|
| Body Temperature | 1 | 2003 | 23 | 0.010 |
Why?
|
| Organizational Objectives | 1 | 2003 | 28 | 0.010 |
Why?
|
| Pulmonary Surfactants | 1 | 2003 | 17 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 2003 | 25 | 0.010 |
Why?
|
| Nuclease Protection Assays | 1 | 2002 | 2 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 6 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 7 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 21 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 2002 | 5 | 0.010 |
Why?
|
| Antimetabolites | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cytosol | 1 | 2002 | 27 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2002 | 13 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 19 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 2002 | 25 | 0.010 |
Why?
|
| Program Development | 1 | 2003 | 98 | 0.010 |
Why?
|
| Focus Groups | 1 | 2003 | 125 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 67 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 77 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 111 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2003 | 190 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 165 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2003 | 130 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 328 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 235 | 0.010 |
Why?
|
| Cytokines | 1 | 2002 | 269 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 484 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 330 | 0.010 |
Why?
|